HIV care and treatment of American Indians/Alaska natives with diagnosed HIV infection – 27 states and the District of Columbia, 2012

Andrew Mitsch, Aruna Surendera Babu, Dean Seneca, Y. Omar Whiteside, Donald Warne

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1% of AIs/ANs were linked to care. At year-end 2012, 46.9% of AIs/ANs were retained in care and 45.1% were virally suppressed. A lower percentage of females (41.3%), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5%) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.

Original languageEnglish (US)
Pages (from-to)953-961
Number of pages9
JournalInternational Journal of STD and AIDS
Volume28
Issue number10
DOIs
StatePublished - Sep 1 2017

Fingerprint

North American Indians
HIV Infections
HIV
Viral Load
Therapeutics
Continuity of Patient Care
Alaska Natives
Centers for Disease Control and Prevention (U.S.)
Age Groups
Health

Keywords

  • Epidemiology
  • HIV
  • North America
  • highly active antiretroviral therapy
  • prevention

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

HIV care and treatment of American Indians/Alaska natives with diagnosed HIV infection – 27 states and the District of Columbia, 2012. / Mitsch, Andrew; Surendera Babu, Aruna; Seneca, Dean; Whiteside, Y. Omar; Warne, Donald.

In: International Journal of STD and AIDS, Vol. 28, No. 10, 01.09.2017, p. 953-961.

Research output: Contribution to journalArticle

@article{d771c777993a4dd1b8b0b9d0473f0231,
title = "HIV care and treatment of American Indians/Alaska natives with diagnosed HIV infection – 27 states and the District of Columbia, 2012",
abstract = "The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1{\%} of AIs/ANs were linked to care. At year-end 2012, 46.9{\%} of AIs/ANs were retained in care and 45.1{\%} were virally suppressed. A lower percentage of females (41.3{\%}), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5{\%}) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.",
keywords = "Epidemiology, HIV, North America, highly active antiretroviral therapy, prevention",
author = "Andrew Mitsch and {Surendera Babu}, Aruna and Dean Seneca and Whiteside, {Y. Omar} and Donald Warne",
year = "2017",
month = "9",
day = "1",
doi = "10.1177/0956462416681183",
language = "English (US)",
volume = "28",
pages = "953--961",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - HIV care and treatment of American Indians/Alaska natives with diagnosed HIV infection – 27 states and the District of Columbia, 2012

AU - Mitsch, Andrew

AU - Surendera Babu, Aruna

AU - Seneca, Dean

AU - Whiteside, Y. Omar

AU - Warne, Donald

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1% of AIs/ANs were linked to care. At year-end 2012, 46.9% of AIs/ANs were retained in care and 45.1% were virally suppressed. A lower percentage of females (41.3%), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5%) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.

AB - The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1% of AIs/ANs were linked to care. At year-end 2012, 46.9% of AIs/ANs were retained in care and 45.1% were virally suppressed. A lower percentage of females (41.3%), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5%) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.

KW - Epidemiology

KW - HIV

KW - North America

KW - highly active antiretroviral therapy

KW - prevention

UR - http://www.scopus.com/inward/record.url?scp=85026729810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026729810&partnerID=8YFLogxK

U2 - 10.1177/0956462416681183

DO - 10.1177/0956462416681183

M3 - Article

C2 - 27872322

AN - SCOPUS:85026729810

VL - 28

SP - 953

EP - 961

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 10

ER -